Evidence map›Paper›PMID 34559303›Full record

ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2022

Opioid requirements in primary versus revision reverse shoulder arthroplasty.

B Gage Griswold, L Fielding Callaway, Matthew R I Meng, Cameron S Murphy, Daniel W Paré, Jessica Amero, Michael J Steflik, Frank D Lewis, Lynn A Crosby, Stephen A Parada

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

B Gage GriswoldDepartment of Orthopaedic Surgery, BA-3300, Augusta University Medical Center, 1120 15th Street, Augusta, GA, 30912, USA. bgriswold@augusta.edu.ORCID http://orcid.org/0000-0002-6784-1088
L Fielding CallawayDepartment of Orthopaedic Surgery, BA-3300, Augusta University Medical Center, 1120 15th Street, Augusta, GA, 30912, USA.
Matthew R I MengDepartment of Orthopaedic Surgery, RAF Lakenheath Medical Hospital, Brandon, UK.
Cameron S MurphyDepartment of Orthopaedic Surgery, BA-3300, Augusta University Medical Center, 1120 15th Street, Augusta, GA, 30912, USA.
Daniel W ParéMedical College of Georgia, Augusta University, Augusta, GA, USA.
Jessica AmeroMedical College of Georgia, Augusta University, Augusta, GA, USA.
Michael J SteflikDepartment of Orthopaedic Surgery, BA-3300, Augusta University Medical Center, 1120 15th Street, Augusta, GA, 30912, USA.
Frank D LewisMedical College of Georgia, Augusta University, Augusta, GA, USA.
Lynn A CrosbyDepartment of Orthopaedic Surgery, VA Medical Center, University of Nebraska, Omaha, NE, USA.
Stephen A ParadaDepartment of Orthopaedic Surgery, BA-3300, Augusta University Medical Center, 1120 15th Street, Augusta, GA, 30912, USA.
Augusta University · USAugusta University Health · USOmaha VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study is to evaluate the inpatient pain medication use of patients who had a revision shoulder arthroplasty procedure performed and compare them to a cohort of patients who had a primary reverse total shoulder arthroplasty (rTSA) performed to determine whether revision shoulder arthroplasty requires more pain medication..

methodsA retrospective review was performed on patients undergoing revision arthroplasty (n = 75) and primary rTSA (n = 340). Inpatient medication records were reviewed to tabulate the visual analog pain (VAS) all narcotic medication use, and total morphine equivalent units (MEUs) were calculated for the duration of the inpatient stay.

resultsThere was no significant difference between groups regarding age, sex, body mass index, Charlson Comorbidity Index, American Society of Anesthesiologists score, preoperative narcotic pain medication use, tobacco use, postoperative VAS scores or hospital length of stay. There were no predictors of total postoperative MEUs identified. Overall, patients in the revision arthroplasty group received significantly less total MEUs than those in the primary rTSA group, 134.96 MEUs vs. 69.79 MEUs, respectively (p < .0005).

conclusionThe perceived notion that revision shoulder arthroplasty is more painful may cause providers to be more inclined to increase narcotic use, or use more invasive pain control techniques. Based on these data, we found that revision shoulder arthroplasty did not require an increased opioid requirement, longer length of stay or increase VAS, suggesting that these patients can often be managed similarly to primary rTSA.

Indexed as

Arthroplasty, Replacement, ShoulderShoulder JointAnalgesics, OpioidArthroplastyHumansMorphine DerivativesNarcoticsPainTreatment OutcomeAnalgesics, OpioidMorphine DerivativesNarcoticsNarcoticsOpioidsPain managementPractice managementShoulder arthroplasty

Identifiers

PMID34559303
OpenAlexW3200026639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.